Unexplained mismatch repair deficiency: Case closed.
Hgg Advances
Eikenboom, Ellis L EL; Moen, Sarah S; van Leeuwen, Lotte L; Geurts-Giele, Willemina R R WRR; Tops, Carli M J CMJ; van Ham, Tjakko J TJ; Dinjens, Winand N M WNM; Dubbink, Hendrikus J HJ; Spaander, Manon C W MCW; Wagner, Anja A
Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2).
Science Signaling
Cocco, Emiliano E; Javier Carmona, F F; Razavi, Pedram P; Won, Helen H HH; Cai, Yanyan Y; Rossi, Valentina V; Chan, Carmen C; Cownie, James J; Soong, Joanne J; Toska, Eneda E; Shifman, Sophie G SG; Sarotto, Ivana I; Savas, Peter P; Wick, Michael J MJ; Papadopoulos, Kyriakos P KP; Moriarty, Alyssa A; Cutler, Richard E RE; Avogadri-Connors, Francesca F; Lalani, Alshad S AS; Bryce, Richard P RP; Chandarlapaty, Sarat S; Hyman, David M DM; Solit, David B DB; Boni, Valentina V; Loi, Sherene S; Baselga, José J; Berger, Michael F MF; Montemurro, Filippo F; Scaltriti, Maurizio M
Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2).
Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc
Hechtman, Jaclyn F JF; Liu, Weiguo W; Sadowska, Justyna J; Zhen, Lisa L; Borsu, Laetitia L; Arcila, Maria E ME; Won, Helen H HH; Shah, Ronak H RH; Berger, Michael F MF; Vakiani, Efsevia E; Shia, Jinru J; Klimstra, David S DS